Home News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth... News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth despite labour code cost February 9, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Aurobindo Pharma Ltd ended at ₹1,201.25, up by ₹10.10, or 0.85%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR AI AI startup Emergent scales at record speed by letting anyone build apps on their phone News Digital loans in India remains a massive opportunity despite tighter regulations, says investor Mayank Kachhwaha News IRCON Intl Q3 net profit up 16% on higher margins; revenue dips; dividend declared 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular Pilgrim’s 24x Growth To ₹400 Cr Revenue And The Offline Retail... Uncategorized February 7, 2026 RBI Plans Rs 25,000 Compensation For Cyber Crime/Fraud Victims Uncategorized February 11, 2026 Lenskart Q3 profit jumps 70% as global business fuels revenue growth Uncategorized February 11, 2026 MobiKwik Turns A Corner, Zupee’s Microdrama Pivot & More Uncategorized February 4, 2026 Import Your ChatGPT Chat Thread To Gemini AI, Sealessly Uncategorized February 11, 2026